FINANCIALS

XLO Xilio Therapeutics Inc 1840233

Income Statement
Revenue	xlo-20240930x10q	2,263,000
Net Income	xlo-20240930x10q	-14,020,000
Profit Margin		-619.53%

Balance Sheet
Current Assets	63,309,000
Assets	74,658,000
Current Liabilities	38,022,000
Liabilities	53,684,000
Equity	20,974,000

Cash Flow Statement
Operating Cash Flow	-4,221,000
Investing Cash Flow	-30,000

Market Analysis
Price	1.14
BVPS	1.88
PB	0.59
PS	3.19
FCF	-4,251,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view XLO documents filed with the SEC.

XLO Filings Clear

View A List of Tickers